Literature DB >> 33000755

Pathogen reduction of blood bank components: a matter of swings and roundabouts.

Albert Farrugia1, Vincenzo De Angelis2.   

Abstract

Mesh：

Year:  2020        PMID： 33000755      PMCID： PMC7605876          DOI： 10.2450/2020.0189-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  17 in total

1.  A recipient of immunoglobulin from a donor who developed vCJD.

Authors:  T El-Shanawany; S Jolles; D J Unsworth; P Williams
Journal:  Vox Sang       Date:  2009-04       Impact factor: 2.144

Review 2.  The long and winding road to pathogen reduction of platelets, red blood cells and whole blood.

Authors:  Paolo Rebulla
Journal:  Br J Haematol       Date:  2019-07-14       Impact factor: 6.998

3.  Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate.

Authors:  J N George; E B Pickett; R Heinz
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

4.  The effect of pathogen inactivation on cryoprecipitate: a functional and quantitative evaluation.

Authors:  Reed W Kamyszek; Matthew W Foster; Brooke A Evans; Keaton Stoner; Jessica Poisson; Amudan J Srinivasan; J Will Thompson; M Arthur Moseley; Micah J Mooberry; Ian J Welsby
Journal:  Blood Transfus       Date:  2020-08-06       Impact factor: 3.443

5.  HIV transmission through transfusion --- Missouri and Colorado, 2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-10-22       Impact factor: 17.586

6.  Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.

Authors:  Niels Rahe-Meyer; Cristina Solomon; Michael Winterhalter; Siegfried Piepenbrock; Kenichi Tanaka; Axel Haverich; Maximilian Pichlmaier
Journal:  J Thorac Cardiovasc Surg       Date:  2009-05-17       Impact factor: 5.209

7.  A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.

Authors:  K Peerlinck; J Arnout; J G Gilles; J M Saint-Remy; J Vermylen
Journal:  Thromb Haemost       Date:  1993-02-01       Impact factor: 5.249

8.  Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.

Authors:  D N Amarapurkar; A Kumar; S Vaidya; P Murti; S K Bichile; R H Kalro; H G Desai
Journal:  Indian J Gastroenterol       Date:  1992-04

9.  Viral safety of coagulation factor concentrates: memoirs from an insider.

Authors:  P M Mannucci
Journal:  J Thromb Haemost       Date:  2018-02-23       Impact factor: 5.824

10.  Fatal West Nile virus infection after probable transfusion-associated transmission--Colorado, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-08-09       Impact factor: 17.586
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.